Impact of adenosine receptors on immunoglobulin production by human peripheral blood B lymphocytes

Journal of Physiology and Pharmacology

Volumn 63, Issue 6, 2012, Pages 661-668

  Sakowicz Burkiewicz, M ^a   Kocbuch, K ^a   Grden, M ^a   Maciejewska, I ^a   Szutowicz, A ^a   Pawelczyk, T ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adenosine receptors; B lymphocyte; Glucose; Immunoglobulin M; Staphyloccocus aureus

Indexed keywords

ADENOSINE A2 RECEPTOR; CYCLIC AMP; GLUCOSE; IMMUNOGLOBULIN M; INTERLEUKIN 2;

ARTICLE; CELL ASSAY; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IN VITRO STUDY; MOLECULAR INTERACTION; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; RECEPTOR DOWN REGULATION; STAPHYLOCOCCUS AUREUS; STIMULUS RESPONSE;

ADENOSINE; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; PURINERGIC P1 RECEPTOR AGONISTS; PURINERGIC P1 RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P1; STAPHYLOCOCCUS AUREUS;

EID: 84873461399     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sakowicz M, Szutowicz A, Pawelczyk T. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes. Int Immunol 2005; 17: 145-154.
2. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Adenosine 5'-triphosphate is the predominant source of peripheral adenosine in human B lymphoblast. J Physiol Pharmacol 2010; 61: 491-499.
3. Pawelczyk T, Grden M, Rzepko R, Sakowicz M, Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol 2005; 167: 315-325.
4. Deussen A, Stappert M, Schafer S, Kelm M. Quantification of extracellular and intracellular adenosine production: understanding the transmembraneus concentration gradient. Circulation 1999; 99: 2041-2047.
5. Sitkovsky MV, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 2005; 5: 712-721.
6. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-39.
7. Bours MJ, Swennen EL, Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006; 112: 358-404.
8. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
9. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev 2008; 7: 759-770.
10. Sakowicz-Burkiewicz M, Pawelczyk T. Recent advances in understanding the relationship between adenosine metabolism and the function of T and B lymphocytes in diabetes. J Physiol Pharmacol 2011; 62: 505-512.
11. Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB. Cutting edge: critical role for A2Aadenosine receptors in the T cell-mediated regulation of colitis. J Immunol 2006; 177: 2765-2769.
12. Sevigny CP, Li L, Awad AS, et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 2007; 178: 4240-4249.
13. + T cells. J Immunol 2005; 174: 1073-1080.
14. Schuetz P, Castro P, Shapiro NI. Diabetes and sepsis: Preclinical findings and clinical relevance. Diabetes Care 2011; 34: 771-778.
15. Grebowska A, Moran AP, Bielanski W, et al. Helicobacter pylori lipopolysaccharide activity in human peripheral blood mononuclear leukocyte cultures. J Physiol Pharmacol 2010; 61: 437-442.
16. Wender-Ozegowska E, Zawiejska A, Michalowska-Wender G, Iciek R, Wender M, Brazert J. Metabolic syndrome in type 1 diabetes mellitus. Does it have impact on the course of pregnancy? J Physiol Pharmacol 2011; 62: 567-573.
17. Joshi M, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912.
18. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Protein kinase C mediated high glucose effect on adenosine receptors expression in rat B lymphocytes. J Physiol Pharmacol 2009; 61: 491-499.
19. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Regulation of adenosine receptors expression in rat B lymphocytes by insulin. J Cell Biochem 2010; 109: 396-405.
20. 2A receptors. Biochem Pharmacol 1999; 57: 65-75.
21. 2A receptors. Naunyn Schmiedebergs Arch Pharmacol 1996; 353: 261-271.
22. 3H]CGS 21680 in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 1996; 354: 539-541.
23. Grden M, Pogorska M, Szutowicz A, Pawelczyk T. Altered expression of adenosine receptors in heart of diabetic rat. J Physiol Pharmacol 2005; 56: 587-597.
24. Grden M, Podgorska M, Szutowicz A, Pawelczyk T. Diabetesinduced alterations of adenosine receptors expression level in rat liver. Exp Mol Pathol 2007; 83: 392-398.
25. Gessi S, Varani K, Merighi S, et al. Adenosine and lymphocyte regulation. Purinergic Signal 2007; 3: 109-116.
26. Ernst PE, Garrison JC, Thompson LF. Much Ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol 2010; 185: 1993-1998.
27. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes. Immunology 2006; 118: 402-412.
28. Pawelczyk T, Sakowicz-Burkiewicz M, Kocbuch K, Szutowicz A. Differential effect of insulin and elevated glucose level on adenosine handling in rat T lymphocytes. J Cell Biochem 2005; 96: 1296-1310.
29. Minhuet S, Huber M, Resenkranz L, Schamel WWA, Reth M, Brummer T. Adenosine and cAMP are potent inhibitors of the NF-oB pathway downstream of immunoreceptors. Eur J Immunol 2005; 35: 31-41.
30. Conigrave AD, Fernando KC, Gu B, et al. P2Y11 receptor expression by human lymphocytes: evidence for two cAMPlinked purinoceptors. Eur J Pharmacol 2001; 426: 157-163.
31. Schuetz P, Castro P, Shapiro NI. Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care 2001; 34: 771-778.
32. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am 1995; 9: 65-96.
33. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007; 30: 2251-2257.
34. Edwards MS, Fuselier PA. Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection. Infect Immun 1983; 39: 580-585.
35. Eibl N, Spatz M, Fischer GF, et al. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin Immunol 2002; 103: 249-259.
36. Liberatore RR, Barbosa SF, Alkimin MG, et al. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2005; 6: 206-212.
37. Rubinstein R, Genaro AM, Motta A, Cremachi G, Wald MR. Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose. Clin Exp Immunol 2008; 154: 235-246.
38. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Maciejewska I, Szutowicz A, Pawelczyk T. High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: involvement of P2X7 receptor. Immunobiology 2012; July 21: [epub ahead of print].